alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › pretreatment

pretreatment

2 studies tagged pretreatment, dated 1989-11-01 to 2011-07-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab 2011-07-01
  2. Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance 1989-11-01

Studies

2 studies carry this tag.

Date range

1989 to 2011

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Laboratory investigation; a journal of technical methods and pathology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab

    ✓ Peer-reviewed alzhub usefulness score 77 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2011-07-01 Treatments

    VE seems to be rare at baseline in patients with AD in clinical trials, 2 of 2,762 associated with AD.

  2. Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Laboratory investigation; a journal of technical methods and pathology 1989-11-01 Drug development

    In Alzheimer's disease, three types of pathologic lesions are stained by thioflavin: neurofibrillary tangles, senile plaques, and amyloidaceous vessels.

All topic tags with their study counts